- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02169778
Effect of Intermittent Versus Continuous Energy Restriction on Compensatory Mechanisms Activated During Weight Reduction
April 28, 2017 updated by: Norwegian University of Science and Technology
Obesity has become a global epidemic with huge public health implications.
Although clinical significant weight loss can be achieved by a combination of diet and behavioral modification, strong metabolic adaptations, with increased appetite and suppressed energy expenditure, are activated, which compromise weight loss maintenance and increase the risk of relapse.
The aim of this project is to compare the effects of intermittent versus continuous energy restriction on the compensatory responses previously described using two low calory diets, with a similar macronutrient distribution.
More specifically, this study will analyze, in the short-term, if an intermittent energy restricted diet is associated with less appetite and low reduction in energy expenditure when compared with a continuous energy restricted diet.
This project can bring large practical benefits concerning the design of weight loss programs to minimize weight relapse.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Trondheim, Norway
- Norwegian University of Science and Technology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adult (18-50 years old)
- obese healthy volunteers (30<BMI<40 kg/m2)
- weight stable on the last three months (<2kg), not currently dieting to lose weight and with an inactive lifestyle
Exclusion Criteria:
- history of endocrine/cardiovascular/pulmonary/kidney disease
- anaemia
- milk intolerance
- depression or other psychological disorders
- eating disorders
- drug or alcohol abuse within the last two years
- current medication known to affect appetite or induce weight loss
- a planned surgery during the study period
- participating in another research study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intermittent energy restricted diet
The intermittent energy restricted group will undergo 3 nonconsecutive days of partial fasting per week.
During the 3 days of partial fasting, participants will be asked to consume a very-low calorie diet (VLCD) providing 550kcal/day for women and 650kcal/day for men.
The VLCD products provide 110kcal/pack and include a variety of shakes, smoothies and soups.
For the feeding days a diet matching energy needs will be prescribed, using meal replacements (such as smoothies, soups and cereal bars) and conventional food.
Drinking at least 2.5 liters of non-caloric liquids will be recommended.
|
|
|
Experimental: Continuous energy restricted diet
The continuous energy restricted group will be prescribed a low calorie diet (LCD) with 33% energy restriction, using meal replacements (such as smoothies, soups and cereal bars) and conventional food.
The diets' macronutrient composition of the two groups will be matched (50% carbohydrates, 20% protein and 30% fat).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Appetite related hormones
Time Frame: 12 weeks after the intervention
|
Appetite-related hormones (active Ghrelin, PYY, GLP-1, CCK) will be measured in fasting and every 30 minutes up to 2,5 hours.
|
12 weeks after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Resting metabolic rate (RMR)
Time Frame: 12 weeks after the intervention
|
RMR measured by indirect calorimetry
|
12 weeks after the intervention
|
|
Exercise efficiency
Time Frame: 12 weeks after the intervention
|
Exercise efficiency measured by graded exercise on a bike
|
12 weeks after the intervention
|
|
Body composition
Time Frame: 12 weeks after the intervention
|
RMR measured by indirect calorimetry
|
12 weeks after the intervention
|
|
Body composition
Time Frame: At 6 months from baseline
|
RMR measured by indirect calorimetry
|
At 6 months from baseline
|
|
Body composition
Time Frame: At 1 year from baseline
|
RMR measured by indirect calorimetry
|
At 1 year from baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Bård Kulseng, MD, PhD, Norwegian University of Science and Technology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Allaf M, Elghazaly H, Mohamed OG, Fareen MFK, Zaman S, Salmasi AM, Tsilidis K, Dehghan A. Intermittent fasting for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013496. doi: 10.1002/14651858.CD013496.pub2.
- Coutinho SR, Halset EH, Gasbakk S, Rehfeld JF, Kulseng B, Truby H, Martins C. Compensatory mechanisms activated with intermittent energy restriction: A randomized control trial. Clin Nutr. 2018 Jun;37(3):815-823. doi: 10.1016/j.clnu.2017.04.002. Epub 2017 Apr 7.
- Castela I, Rodrigues C, Ismael S, Barreiros-Mota I, Morais J, Araujo JR, Marques C, Silvestre MP, Angelo-Dias M, Martins C, Borrego LM, Monteiro R, Coutinho SR, Calhau C, Faria A, Pestana D, Martins C, Teixeira D. Intermittent energy restriction ameliorates adipose tissue-associated inflammation in adults with obesity: A randomised controlled trial. Clin Nutr. 2022 Aug;41(8):1660-1666. doi: 10.1016/j.clnu.2022.06.021. Epub 2022 Jun 18.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2013
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
June 17, 2014
First Submitted That Met QC Criteria
June 19, 2014
First Posted (Estimate)
June 23, 2014
Study Record Updates
Last Update Posted (Actual)
May 2, 2017
Last Update Submitted That Met QC Criteria
April 28, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014/754
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Intermittent energy restricted diet
-
Armed Police Force Hospital, NepalNot yet recruitingOverweight and ObesityNepal
-
Heart and Diabetes Center North-Rhine WestfaliaCompleted
-
Shanghai Jiao Tong University School of MedicineSchool of Public Health, Shanghai Jiao Tong University; Huangpu District Center...CompletedEnergy MetabolismChina
-
Saglik Bilimleri UniversitesiCompletedBlood Pressure | Biochemical Markers | Energy Expenditure | Healthy Eating Index | Anthropometric MeasureTurkey
-
University of BergenKarolinska Institutet; University of Copenhagen; Technical University of Munich; University of GlasgowRecruitingHypertension | Diabetes Mellitus, Type 2 | Insulin Resistance | Glucose Intolerance | Overweight and Obesity | Dyslipidemia Associated With Type II Diabetes MellitusNorway
-
Bezmialem Vakif UniversityCompletedOverweight and ObesityTurkey
-
University of South AlabamaNot yet recruiting
-
Clinical Hospital Center RijekaUniversity of RijekaCompleted
-
Uppsala UniversityAstraZenecaUnknownWeight Loss | Bariatric Surgery Candidate | Type2 Diabetes | Insulin Sensitivity | Metabolism and Nutrition Disorder | Metabolism Disorder, GlucoseSweden